Silexion Therapeutics to Present at the Upcoming 27th Annual H.C. Wainwright Global Investment Conference
(NASDAQ:SLXN) Grand Cayman, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA inte...
2 days ago